Symbiosis boosts injectables capabilities; Accupac adding 300 jobs in CMO expansion;

> CRO InClin has tapped Nextrials for its iPad-based clinical trial management software, Prism. News

> Symbiosis has opened a contract injectables manufacturing plant in Scotland, targeting Phases I and II. Story

> Quintiles has entered a strategic alliance with Dabl, providing the CRO with around-the-clock ambulatory blood pressure measurement for patients in trials. Article

> Accupac is doubling the capacity of its Lakewood, NJ, CMO plant, looking to add 300 jobs once the addition is complete. Report

> Almac has signed on with DSM Pharmaceutical Products ($DSM) to provide sustainable API manufacturing for the company's biocatalysis program. Release

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Galapagos is selling off its contract research organization Fidelta for $37 million to Polish life science company Selvita.

Decentralized study company Medable has raised a large $91 million funding round as it continues to ramp up the deals in 2020.

Biotech IPOs are up over 40% year-to-date, but today’s markets have rewritten the rules for going public. Find out the new best practices for IPOs.